{"id":754029,"date":"2023-05-02T19:04:39","date_gmt":"2023-05-02T23:04:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/"},"modified":"2023-05-02T19:04:39","modified_gmt":"2023-05-02T23:04:39","slug":"atai-life-sciences-to-participate-in-upcoming-may-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/","title":{"rendered":"atai Life Sciences to Participate in Upcoming May Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK and BERLIN, May  02, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KLdhzwvrX-KN9oCc5GjJOj8-ZbZajeyeuHL4upkQ8epNjV3ZlvVYQjtzXEfiULSiFum81DfR_5RCctIf8QzFv_s3fnfoJmBnyJRaiylwzC9dxMMJO_22Ki5wvJqf0rw0NpcRA69WI4tMFwoBvwmIEi9sjAIqaCE-CWCNdS9VY3Fp7lR4MdihEEAfdd_C6_lr9YU9qIPcJR7ResCrhv7MW0V5f3zCWSjNmFX2pTRXmYFgwnVOZbVjg43ahvUVfTUpgx3e6K9hpKkjIXdlaH2dS2F_c2pkc5gQD_WxGY-8g0uOIkP6xnao0ZMzChDTuhBHtpmEkc-WZDNEU0BXg8k3tfYEk6UIEj_PqcCcRgxcQeUuFH-Ms0hAxCRP6Y25oHDgQn9WVbEihSZJNxtot-jIltXAzOLdWSY14CA7yvrQNWY=\" rel=\"nofollow noopener\" target=\"_blank\">atai Life Sciences<\/a>\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Aegis Virtual Conference.<\/p>\n<p>Details of the company\u2019s presentation is as follows:<\/p>\n<p>\n        <strong>Aegis Virtual Conference<br \/><\/strong>Format: Corporate Presentation<br \/>Date and Time: Wednesday, May 3<sup>rd<\/sup>, 11:30 a.m. ET<br \/>Location: Virtual<\/p>\n<p>A live webcast of the presentation will be available on atai\u2019s website under Events on the Investors section of the atai website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RERS7wIjaQuCysiHKzKYMeN9G_ZqNl_oVBIRdFvFKgTlXKgLyynhJULIahCyyN6mIMd_sP7TDsuYRlvUBMAzDqvtP26zBa5AAcEOmWeobFiEhfnyqy1BD73qO0vLuAnclHFkPsBvlGR7Byb2cAiLSg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.atai.life\/news-events\/events\/<\/a>. An archived replay of the webcast will be available for up to 30 days following the presentation.<\/p>\n<p>\n        <strong>About atai Life Sciences<\/strong>\n      <\/p>\n<p>atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.<\/p>\n<p>By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies to achieve clinically meaningful and sustained behavioral change in mental health patients.<\/p>\n<p>atai&#8217;s vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1_USs1HCf1_nIeW0DPTLC5z1Is6dh7lZDzKidXTP3bDurinO4gLk-086Ts7TnC4EHqfHbnNSLl-ZCt16Bk3CxT5R7bNN5_yNkcs9gCCi1r8necArnQVII8iIQWmmTN_hFIHx0tKcPSjtma0gpOpelC2c0-lW-Fv_eE8AL-TAkrqig9SsEiub2ygqrWlLXO5BuoT6-ibd99ZwpVBwP1j9vYXirdDUdH7GVG9S6GGDIA=\" rel=\"nofollow noopener\" target=\"_blank\">www.atai.life<\/a>.<\/p>\n<p>\n        <strong>Contact Information<\/strong>\n      <\/p>\n<p>Investor Contact:<br \/>Stephen Bardin<br \/>Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lu2rNAmEunn07zhY2vO-iUyXLlJSBng2Vbc5JlmCm901-lLVp0LymHlZ4otNmASgO79mQIRqFDVCsIFDECDCXA==\" rel=\"nofollow noopener\" target=\"_blank\">IR@atai.life<\/a><\/p>\n<p>Media Contact:<br \/>Allan Malievsky<br \/>Senior Director, External Affairs<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NY-PEj7wnXEFTGF2LC5lQaSnalSCwsyCrr4In2aIcjNVgC-VjYy2IRZNVYzsYHxGlKS9xknktGxfcbXfsDagUA==\" rel=\"nofollow noopener\" target=\"_blank\">PR@atai.life<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDkzZDNiZmEtMGY4ZC00MDBkLTk0NTgtMjViMjg3ZjgzODE3LTEyMTgxNDI=\/tiny\/Atai-Life-Sciences-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) &#8212; atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Aegis Virtual Conference. Details of the company\u2019s presentation is as follows: Aegis Virtual ConferenceFormat: Corporate PresentationDate and Time: Wednesday, May 3rd, 11:30 a.m. ETLocation: Virtual A live webcast of the presentation will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. An archived replay of the webcast will be available for up to 30 days following the presentation. About atai Life Sciences atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;atai Life Sciences to Participate in Upcoming May Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754029","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) &#8212; atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Aegis Virtual Conference. Details of the company\u2019s presentation is as follows: Aegis Virtual ConferenceFormat: Corporate PresentationDate and Time: Wednesday, May 3rd, 11:30 a.m. ETLocation: Virtual A live webcast of the presentation will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. An archived replay of the webcast will be available for up to 30 days following the presentation. About atai Life Sciences atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded &hellip; Continue reading &quot;atai Life Sciences to Participate in Upcoming May Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T23:04:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"atai Life Sciences to Participate in Upcoming May Investor Conference\",\"datePublished\":\"2023-05-02T23:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/\",\"name\":\"atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\",\"datePublished\":\"2023-05-02T23:04:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"atai Life Sciences to Participate in Upcoming May Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk","og_description":"NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) &#8212; atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Aegis Virtual Conference. Details of the company\u2019s presentation is as follows: Aegis Virtual ConferenceFormat: Corporate PresentationDate and Time: Wednesday, May 3rd, 11:30 a.m. ETLocation: Virtual A live webcast of the presentation will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. An archived replay of the webcast will be available for up to 30 days following the presentation. About atai Life Sciences atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded &hellip; Continue reading \"atai Life Sciences to Participate in Upcoming May Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-02T23:04:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"atai Life Sciences to Participate in Upcoming May Investor Conference","datePublished":"2023-05-02T23:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/","name":"atai Life Sciences to Participate in Upcoming May Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=","datePublished":"2023-05-02T23:04:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQ5MyM1NTcwOTkxIzIyMDY1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-may-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"atai Life Sciences to Participate in Upcoming May Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754029"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754029\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}